Work

Metabolic profiling of neurodegenerative diseases: With emphasis on Alzheimer's disease and C9ORF72-gene hexanucleotide repeat expansion associated frontotemporal lobar degeneration

Year: 2022
Type: dissertation
Abstract: An increasing number of studies have reported metabolic changes during the onset and course of neurodegenerative diseases, particularly in Alzheimer's disease (AD).These changes associate not only with disease pathogenesis, but also with the relative risk of onset, the latter making them attractive as diagnostic biomarkers.Furthermore, many neurodegenerative diseases share common risk factors with metabolic diseases and many mechanistic features of neurodegeneration share commonalities with some of the origins of metabolic perturbations, such as apolipoprotein E polymorphisms or elevated oxidative stress.Neurodegenerative diseases are a set of progressive illnesses characterized by steadily declining cognitive abilities with corresponding brain pathologies.The most common neurodegenerative diseases is Alzheimer's Disease (AD) which affects the lives of millions of people worldwide, not only the suffers but their families and carers as well, and, in total, creates a substantial economic burden.AD has distinct preclinical and prodromal phases, wherein pathological changes have already taken place, but clinical symptoms are non-existent or mild.Other neurodegenerative diseases, including frontotemporal lobar degeneration (FTLD), vascular dementia (VD), Parkinson's disease (PD), dementia with
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7215321690
Cites: 349
Cited by:
Related to: 10